Determination of heparan sulphate in kidney tissues of patients with calcium nephrolithiasis.
While the pathogenic mechanisms responsible for calcium nephrolithiasis remain unknown, the influence of heparan sulphate proteoglycan (HSPG) on disease progression of other diseases, such as polycystic kidneys and diabetic glomerulosclerosis, makes it an important candidate for the study of stone formation. Using the indirect immunofluorescence assay and image analysis, we were able to quantify and visualize the loss of HSPG localized in the basement membrane of the glomerulus and the mucosa of ureter or renal pelvis in patients with recurrent calcium nephrolithiasis as compared to normal subjects. However, no significant change in HSPG was observed in the basement membrane of the tubular epithelium. The decreased HSPG in the glomerulus may reflect the potentially disrupted anion/neutral barrier for glomerular filtration, which would encourage the accumulation of stone solutes. The drop in HSPG staining intensity in the basement membrane of the mucosa of ureter/renal pelvis may suggest the tendency of adhesion of crystal to urothelial surfaces. Based on these immunological data, it appears that HSPG plays a modulatory role in the pathogenesis of this disease.
Chan
V S
VS
Department of Clinical Research, Ministry of Health, Singapore.
Tan
E C
EC
Li
M K
MK
D000328:Adult; D001485:Basement Membrane / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D019084:Fluorescent Antibody Technique, Indirect; D006497:Heparan Sulfate / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D007669:Kidney Calculi / Q000378:metabolism*; D007678:Kidney Glomerulus / Q000378:metabolism; D007682:Kidney Pelvis / Q000378:metabolism; D007684:Kidney Tubules / Q000378:metabolism; D008875:Middle Aged; D014018:Tissue Distribution; D014513:Ureter / Q000378:metabolism
D002118:Calcium; D006497:Heparan Sulfate